CN106693050B - A preparation method of composite scaffold material based on collagen and collagen fibers - Google Patents
A preparation method of composite scaffold material based on collagen and collagen fibers Download PDFInfo
- Publication number
- CN106693050B CN106693050B CN201710109808.7A CN201710109808A CN106693050B CN 106693050 B CN106693050 B CN 106693050B CN 201710109808 A CN201710109808 A CN 201710109808A CN 106693050 B CN106693050 B CN 106693050B
- Authority
- CN
- China
- Prior art keywords
- collagen
- solution
- composite
- fibers
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001436 collagen Polymers 0.000 title claims abstract description 160
- 102000008186 Collagen Human genes 0.000 title claims abstract description 128
- 108010035532 Collagen Proteins 0.000 title claims abstract description 128
- 239000002131 composite material Substances 0.000 title claims abstract description 83
- 239000000835 fiber Substances 0.000 title claims abstract description 82
- 239000000463 material Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 150000004676 glycans Chemical class 0.000 claims abstract description 23
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 23
- 239000005017 polysaccharide Substances 0.000 claims abstract description 23
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229910021389 graphene Inorganic materials 0.000 claims abstract description 19
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 18
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 18
- 238000010146 3D printing Methods 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 12
- 229920001661 Chitosan Polymers 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 10
- 239000000243 solution Substances 0.000 claims description 46
- 230000008961 swelling Effects 0.000 claims description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 239000011550 stock solution Substances 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 239000007974 sodium acetate buffer Substances 0.000 claims description 5
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 238000012546 transfer Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 4
- 238000000465 moulding Methods 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims description 2
- 210000002435 tendon Anatomy 0.000 claims 3
- 238000012360 testing method Methods 0.000 claims 3
- 241000283074 Equus asinus Species 0.000 claims 1
- 206010070834 Sensitisation Diseases 0.000 claims 1
- 231100000433 cytotoxic Toxicity 0.000 claims 1
- 230000001472 cytotoxic effect Effects 0.000 claims 1
- 230000003013 cytotoxicity Effects 0.000 claims 1
- 231100000135 cytotoxicity Toxicity 0.000 claims 1
- 229910001385 heavy metal Inorganic materials 0.000 claims 1
- 230000036512 infertility Effects 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 230000008313 sensitization Effects 0.000 claims 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 6
- 238000005516 engineering process Methods 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 230000017423 tissue regeneration Effects 0.000 abstract 2
- 230000003592 biomimetic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000007787 electrohydrodynamic spraying Methods 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 20
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000013475 authorization Methods 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/08—Carbon ; Graphite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/108—Elemental carbon, e.g. charcoal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2389/00—Characterised by the use of proteins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2401/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2401/08—Cellulose derivatives
- C08J2401/26—Cellulose ethers
- C08J2401/28—Alkyl ethers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
- C08J2405/02—Dextran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
- C08J2405/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Manufacturing & Machinery (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
本发明公开了一种基于胶原及胶原纤维的复合支架材料的制备方法,其特点是将胶原与其聚集态结构体胶原纤维有机混合,并使用功能性氧化多糖与氧化石墨烯对胶原‑胶原纤维复合溶液进行复合协同改性,接着,将胶原‑胶原纤维复合溶液与一定量的壳聚糖、聚乙烯醇共混,然后经过3D打印、微波干燥成膜、电喷涂、灭菌等工艺,最后获得基于胶原及胶原纤维的复合支架材料的制备方法。该材料采用仿生性更强的天然胶原结构的胶原纤维,并利用3D打印技术对支架微观结构与形貌进行生物设计,从化学组成与天然结构上充分仿生天然活性组织,所得支架材料结构稳定、理化性能优越,具有良好的细胞相容性和生物降解性,并能诱导组织再生修复,可用作各类型的组织工程支架。The invention discloses a preparation method of a composite scaffold material based on collagen and collagen fibers, which is characterized in that collagen is organically mixed with its aggregated structure collagen fibers, and functional oxidized polysaccharides and graphene oxide are used to compound collagen-collagen fibers The solution is compounded and synergistically modified, and then the collagen-collagen fiber composite solution is blended with a certain amount of chitosan and polyvinyl alcohol, and then undergoes processes such as 3D printing, microwave drying, electrospraying, and sterilization to obtain A method for preparing a composite scaffold material based on collagen and collagen fibers. The material uses collagen fibers with a stronger biomimetic natural collagen structure, and uses 3D printing technology to biodesign the microstructure and morphology of the scaffold, fully imitating natural active tissues from the chemical composition and natural structure, and the obtained scaffold material has a stable structure, It has superior physical and chemical properties, good cell compatibility and biodegradability, and can induce tissue regeneration and repair, and can be used as various types of tissue engineering scaffolds.
Description
技术领域technical field
本发明涉及了一种基于胶原及胶原纤维的复合支架材料,属于生物医用材料制备领域。The invention relates to a composite support material based on collagen and collagen fibers, belonging to the field of biomedical material preparation.
背景技术Background technique
组织工程支架是组织工程化组织的最基本构架,为细胞和组织生长提供适宜的环境,并随着组织的构建而逐渐降解和消失,从而将新的空间提供给组织和细胞。该结构是细胞获取营养、气体交换、废物排泄和生长代谢的场所,是形成新的具有一定形态和功能的组织、器官的基础。数十年来,人们一直通过一个“两步法”制造活性组织。第一步是使用某种生物可降解材料设计组织的支架。为了使用传统方法制造设计的支架,研究人员需要为它建模、雕刻出来,或使用化学品蚀刻出一个多孔的形状。第二步是利用活细胞培育出一个支架。大量研究证明,这些技术存在许多弊端,比如大量使用高毒性的有机溶剂,制造周期长,劳动密集型流程,无法完全除去聚合物基体中的残留物,可重复性差,孔隙呈现不规则形状,孔隙间无法充分连接,结构偏薄等等。此外,这些方法多数无法控制形状。Tissue engineering scaffold is the most basic structure of tissue engineering tissue, which provides a suitable environment for the growth of cells and tissues, and gradually degrades and disappears with the construction of tissues, thus providing new space for tissues and cells. This structure is the place where cells obtain nutrients, gas exchange, waste excretion and growth metabolism, and is the basis for forming new tissues and organs with certain shapes and functions. For decades, living tissue has been produced through a "two-step process". The first step is to design a scaffold for the tissue using some kind of biodegradable material. To fabricate a designed scaffold using traditional methods, researchers model it, sculpt it, or use chemicals to etch a porous shape. The second step is to grow a scaffold using living cells. A large number of studies have proved that these technologies have many disadvantages, such as a large amount of highly toxic organic solvents, long manufacturing cycles, labor-intensive processes, inability to completely remove residues in the polymer matrix, poor reproducibility, and irregular pores. The space cannot be fully connected, the structure is too thin, and so on. Furthermore, most of these methods cannot control the shape.
与这种方法相比,3D打印可精确地打印出所需组织的形状和结构。3D打印的骨植入物、牙冠、隐形眼镜与助听器等无生命修复形式已经存在于世界各地成千上万人的体内。目前,3D打印身体部位采用单一的材料,如金属、陶瓷或塑料。它们具有商业意义,因为它们的市场价值来自它们能够与一个形状特殊的身体紧密贴合。然而,这些材料也仅仅能成为无生命的替换部位,真正的3D生物打印应为创造活性组织。生物打印,即“活墨”的使用,内部悬浮着活细胞的可打印凝胶。将活细胞与“间隙填充物”(如胶原,以暂时填充空间直到与其他细胞融合)打印出人体组织许多特殊且精密的形状,活细胞分泌出物质进入水凝胶,从而最终形成一个支撑母体。随着细胞的生长,母体发展为活性组织。Compared with this method, 3D printing can precisely print the shape and structure of the desired tissue. 3D printed forms of inanimate restorations such as bone implants, dental crowns, contact lenses and hearing aids are already in the bodies of thousands of people around the world. Currently, 3D printed body parts use a single material such as metal, ceramic or plastic. They make commercial sense because their market value comes from their ability to fit snugly to a specially shaped body. However, these materials can only become inanimate replacement parts, and the real 3D bioprinting should be to create living tissues. Bioprinting, the use of "living ink," a printable gel with living cells suspended inside. Living cells are printed with "gap fillers" (such as collagen, to temporarily fill the space until they fuse with other cells) to create many special and precise shapes of human tissue. The living cells secrete substances into the hydrogel, which ultimately forms a supporting matrix. . As the cells grow, the matrix develops into living tissue.
胶原及胶原纤维,具有良好的生物相容性和生物可降解性,以及促进细胞生长与粘附的性能,且具有pH和温度敏感性,利于成型,已被应用于3D打印活性组织领域。然而,纯胶原或胶原纤维的3D打印活性组织在力学性能上还不足以支撑起一定形状的组织,因此添加其它生物材料或是微量的交联剂成为3D打印过程中必要的元素。Collagen and collagen fibers have good biocompatibility and biodegradability, as well as the ability to promote cell growth and adhesion, and are pH and temperature sensitive, which is good for molding. They have been used in the field of 3D printing living tissues. However, the mechanical properties of 3D printed active tissue of pure collagen or collagen fibers are not enough to support a certain shape of tissue, so adding other biomaterials or a small amount of cross-linking agent becomes a necessary element in the 3D printing process.
因此本专利所获得的一种基于胶原及胶原纤维的复合支架材料的方法在3D打印活性组织领域具有广阔的应用前景。Therefore, the method of a composite scaffold material based on collagen and collagen fibers obtained in this patent has broad application prospects in the field of 3D printing of living tissues.
发明内容Contents of the invention
本发明的目的是针对现有相关技术的不足而提供了一种基于胶原及胶原纤维的复合支架材料。该支架材料细胞相容性优异,非常有利于细胞的生长、增殖及迁移,细胞能够较好地长入支架内部,又具有一定的抗炎、抗氧化、抗菌等功效,生物活性好,可用作组织工程支架。The object of the present invention is to provide a composite scaffold material based on collagen and collagen fibers to address the deficiencies of the prior art. The scaffold material has excellent cytocompatibility, which is very conducive to the growth, proliferation and migration of cells. Cells can grow into the scaffold well, and has certain anti-inflammatory, anti-oxidation, antibacterial and other effects. It has good biological activity and can be used as a scaffold for tissue engineering.
本发明的目的可以由以下制备技术来实现,其制备方法步骤如下:The object of the present invention can be realized by following preparation technology, and its preparation method step is as follows:
(1)基于氧化多糖和氧化石墨烯的胶原-胶原纤维复合溶胀液的制备:将按质量比为1~9∶9~1的1~2重量份的胶原及胶原纤维混合,4~10℃下搅拌将其溶胀于pH为4.0的醋酸-醋酸钠缓冲体系中,得到浓度为1~2wt%的胶原-胶原纤维复合溶胀液;接着向上述复合溶胀液中加入0.05~0.4重量份的氧化多糖,4~10℃下避光反应10~24h,待反应完成后,再向复合溶胀液加入0.01~0.2重量份的氧化石墨烯,4~10℃下继续反应24~48h,得到基于氧化多糖和氧化石墨烯的胶原-胶原纤维复合溶胀液;(1) Preparation of collagen-collagen fiber composite swelling solution based on oxidized polysaccharide and graphene oxide: mix 1-2 parts by weight of collagen and collagen fiber with a mass ratio of 1-9:9-1, and heat at 4-10°C Swell it in an acetic acid-sodium acetate buffer system with a pH of 4.0 under stirring to obtain a collagen-collagen fiber composite swelling solution with a concentration of 1 to 2 wt %; then add 0.05 to 0.4 parts by weight of oxidized polysaccharide to the above composite swelling solution , react in the dark at 4-10°C for 10-24h, after the reaction is complete, add 0.01-0.2 parts by weight of graphene oxide to the composite swelling solution, and continue the reaction at 4-10°C for 24-48h to obtain a polysaccharide based on oxidized polysaccharide and Graphene oxide collagen-collagen fiber composite swelling solution;
(2)基于胶原及胶原纤维的复合支架材料的原液的制备:将0.5~1.5重量份的壳聚糖加入到上述胶原-胶原纤维复合溶胀液,4~10℃下搅拌至全部溶解,得到混合液A;在40~80℃下将6~12重量份的聚乙烯醇溶解在去离子水中,得到浓度为6~12wt%的聚乙烯醇水溶液;将按体积比为1~10∶0.01~2的混合A液与聚乙烯醇水溶液混合,4~10℃下搅拌至充分共溶,得到基于胶原及胶原纤维的复合支架材料的原液;(2) Preparation of stock solution of composite scaffold material based on collagen and collagen fibers: add 0.5-1.5 parts by weight of chitosan to the above-mentioned collagen-collagen fiber composite swelling solution, stir at 4-10°C until completely dissolved, and obtain a mixed Solution A: Dissolve 6-12 parts by weight of polyvinyl alcohol in deionized water at 40-80°C to obtain an aqueous solution of polyvinyl alcohol with a concentration of 6-12wt%; the volume ratio will be 1-10:0.01-2 The mixed liquid A is mixed with polyvinyl alcohol aqueous solution, and stirred at 4-10°C until fully co-dissolved to obtain a stock solution of a composite scaffold material based on collagen and collagen fibers;
(3)基于胶原及胶原纤维的复合支架材料的制备:根据所需支架形态、结构采用计算机辅助设计软件编制出控制平台移动的程序,将上述基于胶原及胶原纤维的复合支架材料的原液注入3D生物打印机,3D打印成型得到胶原-胶原纤维复合支架,并将复合支架转移至微波干燥机上成膜;随后接着将1~2重量份胶原溶液在0.05~0.5M的醋酸溶液中,配制成浓度为1~2wt%的胶原溶液胶原,使用静电喷涂机将上述胶原溶液喷涂在胶原-胶原纤维复合支架正反两面,最终经冷冻干燥、剂量为 6~30KGy/h60Co所产生的γ射线消毒灭菌,成型包装,得到基于胶原及胶原纤维的复合支架材料的最终成品。(3) Preparation of composite scaffold materials based on collagen and collagen fibers: According to the required scaffold shape and structure, computer-aided design software was used to compile a program to control the movement of the platform, and the stock solution of the composite scaffold materials based on collagen and collagen fibers was injected into the 3D Bioprinter, 3D printing to obtain a collagen-collagen fiber composite scaffold, and transfer the composite scaffold to a microwave dryer to form a film; then 1 to 2 parts by weight of collagen solution in 0.05 to 0.5M acetic acid solution to prepare a concentration of 1-2wt% collagen solution collagen, spray the above-mentioned collagen solution on the front and back sides of the collagen-collagen fiber composite scaffold with an electrostatic sprayer, and finally freeze-dry and sterilize it with gamma rays produced by 60KGy/h 60 Co Bacteria, molding and packaging to obtain the final product of the composite scaffold material based on collagen and collagen fibers.
在上述的制备方法中,步骤(1)中使用氧化多糖为将羧甲基纤维素、透明质酸、壳聚糖、葡聚糖等经高碘酸钠氧化所得,具体制备方法参照本课题组前期公开专利[但卫华,刘新华,但年华,等. 具有抗菌/抑菌功效的胶原集合体复合型医用纤维. 中国发明专利.201510127304.9;但年华,但卫华,刘新华,等. 氧化壳寡糖及其制备方法. 专利授权号:CN104004112 A;但卫华,刘新华,但年华,等. 氧化壳聚糖接枝改性猪真皮胶原微纳纤维膜及其制备方法.专利授权号:CN 104013995 A];步骤(1)中所述的氧化石墨烯、聚乙烯醇、壳聚糖均为医用级;步骤(1)中胶原及胶原纤维的复合支架材料的3D打印程序需根据具体支架用途、形态、精细结构而定。In the above preparation method, the oxidized polysaccharide used in step (1) is obtained by oxidizing carboxymethyl cellulose, hyaluronic acid, chitosan, dextran, etc. with sodium periodate. For the specific preparation method, please refer to our research group Early published patents [Dan Weihua, Liu Xinhua, Dan Nianhua, etc. Collagen Aggregate Composite Medical Fiber with Antibacterial/Bacteriostatic Effects. Chinese Invention Patent. 201510127304.9; Dan Nianhua, Dan Weihua, Liu Xinhua, etc. Sugar and its preparation method. Patent authorization number: CN104004112 A; Dan Weihua, Liu Xinhua, Dan Nianhua, etc. Oxidized chitosan grafted modified porcine dermal collagen micro-nano fiber membrane and its preparation method. Patent authorization number: CN 104013995 A]; the graphene oxide, polyvinyl alcohol, and chitosan described in step (1) are all medical grade; the 3D printing procedure of the composite scaffold material of collagen and collagen fibers in step (1) needs to be based on the specific scaffold use, Depends on shape and fine structure.
本发明有以下优点:The present invention has the following advantages:
(1)与已有大多报道的胶原类支架材料不同,本发明采用了胶原与胶原纤维,其中胶原纤维为胶原的聚集体,其结构更为复杂,更能仿生活性组织体内胶原的存在结构形态,研究表明其理化性能、生物活性、组织诱导再生修复能力均显著较强;(1) Different from most of the collagen-based scaffold materials reported, the present invention uses collagen and collagen fibers, in which collagen fibers are aggregates of collagen, and its structure is more complex, which can better imitate the existing structure of collagen in living tissues , studies have shown that its physical and chemical properties, biological activity, tissue induction regenerative repair ability are significantly stronger;
(2)本发明采用氧化多糖与氧化石墨烯为胶原的改性剂,一方面氧化多糖能与胶原发生席夫碱键结合达到有效交联的效果,且多糖经氧化后仍能保持其本体的功能性,非常有利于功能化胶原的制备;另一方面是氧化石墨烯能够在不影响胶原生物活性的同时,可显著增强胶原的理化性能,且能赋予胶原一定的抗菌/抑菌性;(2) The present invention uses oxidized polysaccharides and graphene oxide as collagen modifiers. On the one hand, oxidized polysaccharides can be combined with collagen to achieve Schiff base bonds to achieve effective cross-linking effects, and the polysaccharides can still maintain their bulk after oxidation. Functionality is very beneficial to the preparation of functionalized collagen; on the other hand, graphene oxide can significantly enhance the physical and chemical properties of collagen without affecting the biological activity of collagen, and can endow collagen with certain antibacterial/bacteriostatic properties;
(3)采用3D打印技术能够对支架的形态、微观结构等进行仿生生物设计,通过调控支架的微观结构、形貌以实现对细胞的长入、生长的控制。(3) The use of 3D printing technology can carry out bionic biological design on the shape and microstructure of the scaffold, and control the ingrowth and growth of cells by regulating the microstructure and shape of the scaffold.
具体实施方式Detailed ways
下面通过实施对本发明进行具体的描述,有必要在此指出的是本实施例只用于对本发明做进一步说明,而不能理解为对本发明保护范围的限制,该领域的技术熟练人员可以根据上述发明的内容作出非本质的改进和调整。The present invention will be specifically described below by implementing it. It is necessary to point out that this embodiment is only used to further illustrate the present invention, and can not be interpreted as limiting the protection scope of the present invention. Make non-essential improvements and adjustments to the content.
实施例1Example 1
(1)基于氧化多糖和氧化石墨烯的胶原-胶原纤维复合溶胀液的制备:将按质量比为1∶9的1重量份的胶原及胶原纤维混合,4℃下搅拌将其溶胀于pH为4.0的醋酸-醋酸钠缓冲体系中,得到浓度为1wt%的胶原-胶原纤维复合溶胀液;接着向上述复合溶胀液中加入0.05重量份的氧化多糖,4℃下避光反应24h,待反应完成后,再向复合溶胀液中加入0.2重量份的氧化石墨烯,4℃下继续反应48h,得到基于氧化多糖和氧化石墨烯的胶原-胶原纤维复合溶胀液;(1) Preparation of collagen-collagen fiber composite swelling liquid based on oxidized polysaccharide and graphene oxide: Mix 1 part by weight of collagen and collagen fiber with a mass ratio of 1:9, stir at 4°C and swell it at a pH of In the acetic acid-sodium acetate buffer system of 4.0, a collagen-collagen fiber composite swelling solution with a concentration of 1wt% was obtained; then, 0.05 parts by weight of oxidized polysaccharide was added to the above composite swelling solution, and reacted in the dark at 4°C for 24 hours until the reaction was completed Finally, add 0.2 parts by weight of graphene oxide to the composite swelling solution, and continue to react for 48 hours at 4°C to obtain a collagen-collagen fiber composite swelling solution based on oxidized polysaccharides and graphene oxide;
(2)基于胶原及胶原纤维的复合支架材料原液的制备:将0.5重量份的壳聚糖加入到上述胶原-胶原纤维复合溶胀液中,4℃下搅拌至全部溶解,得到混合液A;在40℃下将6重量份的聚乙烯醇溶解在去离子水中,得到浓度为6wt%的聚乙烯醇水溶液;将按体积比为1∶2的混合A液与聚乙烯醇水溶液混合,4℃下搅拌至充分共溶,得到基于胶原及胶原纤维的复合支架材料的原液;(2) Preparation of the stock solution of the composite scaffold material based on collagen and collagen fibers: add 0.5 parts by weight of chitosan to the above-mentioned collagen-collagen fiber composite swelling solution, stir at 4°C until completely dissolved, and obtain the mixed solution A; Dissolve 6 parts by weight of polyvinyl alcohol in deionized water at 40°C to obtain a polyvinyl alcohol aqueous solution with a concentration of 6wt%; mix the mixed liquid A with a volume ratio of 1:2 with the polyvinyl alcohol aqueous solution, and Stir until fully co-dissolved to obtain a stock solution of a composite scaffold material based on collagen and collagen fibers;
(3)基于胶原及胶原纤维的复合支架材料的制备:根据所需支架形态、结构采用计算机辅助设计软件编制出控制平台移动的程序,将上述基于胶原及胶原纤维的复合支架材料的原液注入3D生物打印机,3D打印成型得到胶原-胶原纤维复合支架,并将复合支架转移至在微波干燥机上成膜;随后接着将1重量份胶原溶液在0.05M的醋酸溶液中,配制成浓度为1wt%的胶原溶液胶原,使用静电喷涂机将上述胶原溶液喷涂在胶原-胶原纤维复合支架正反两面,最终经冷冻干燥、剂量为 6KGy/h60Co所产生的γ射线消毒灭菌,成型包装,得到基于胶原及胶原纤维的复合支架材料的最终成品。(3) Preparation of composite scaffold materials based on collagen and collagen fibers: According to the required scaffold shape and structure, computer-aided design software was used to compile a program to control the movement of the platform, and the stock solution of the composite scaffold materials based on collagen and collagen fibers was injected into the 3D Bioprinter, 3D printing to obtain a collagen-collagen fiber composite scaffold, and transfer the composite scaffold to a microwave dryer to form a film; then 1 weight part of collagen solution in 0.05M acetic acid solution to prepare a concentration of 1wt% Collagen solution collagen, using an electrostatic sprayer to spray the above collagen solution on the front and back sides of the collagen-collagen fiber composite support, and finally freeze-dried, sterilized and sterilized by gamma rays produced by 6KGy/h 60 Co, molded and packaged, and obtained based on The final product of the composite scaffold material of collagen and collagen fibers.
实施例2Example 2
(1)基于氧化多糖和氧化石墨烯的胶原-胶原纤维复合溶胀液的制备:将按质量比为3∶7的1.5重量份的胶原及胶原纤维混合,5℃下搅拌将其溶胀于pH为4.0的醋酸-醋酸钠缓冲体系中,得到浓度为1.5wt%的胶原-胶原纤维复合溶胀液;接着向上述复合溶胀液中加入0.2重量份的氧化多糖,5℃下避光反应15h,待反应完成后,再向复合溶胀液加入0.1重量份的氧化石墨烯,5℃下继续反应24~48h,得到基于氧化多糖和氧化石墨烯的胶原-胶原纤维复合溶胀液;(1) Preparation of collagen-collagen fiber composite swelling liquid based on oxidized polysaccharide and graphene oxide: mix 1.5 parts by weight of collagen and collagen fiber with a mass ratio of 3:7, stir at 5°C and swell it at a pH of In the acetic acid-sodium acetate buffer system of 4.0, a collagen-collagen fiber composite swelling solution with a concentration of 1.5wt% was obtained; then, 0.2 parts by weight of oxidized polysaccharide was added to the above-mentioned composite swelling solution, and reacted in the dark at 5°C for 15 hours. After completion, add 0.1 parts by weight of graphene oxide to the composite swelling solution, and continue the reaction at 5°C for 24 to 48 hours to obtain a collagen-collagen fiber composite swelling solution based on oxidized polysaccharide and graphene oxide;
(2)基于胶原及胶原纤维的复合支架材料的原液的制备:将1重量份的壳聚糖加入到上述胶原-胶原纤维复合溶胀液,5℃下搅拌至全部溶解,得到混合液A;在60℃下将8重量份的聚乙烯醇溶解在去离子水中,得到浓度为8wt%的聚乙烯醇水溶液;将按体积比为5∶1的混合A液与聚乙烯醇水溶液混合,5℃下搅拌至充分共溶,得到基于胶原及胶原纤维的复合支架材料的原液;(2) Preparation of stock solution of composite scaffold material based on collagen and collagen fibers: add 1 part by weight of chitosan to the above-mentioned collagen-collagen fiber composite swelling solution, stir at 5°C until completely dissolved, and obtain mixed solution A; Dissolve 8 parts by weight of polyvinyl alcohol in deionized water at 60°C to obtain a polyvinyl alcohol aqueous solution with a concentration of 8wt%; mix the mixed liquid A with a volume ratio of 5:1 with the polyvinyl alcohol aqueous solution, and Stir until fully co-dissolved to obtain a stock solution of a composite scaffold material based on collagen and collagen fibers;
(3)基于胶原及胶原纤维的复合支架材料的制备:根据所需支架形态、结构采用计算机辅助设计软件编制出控制平台移动的程序,将上述基于胶原及胶原纤维的复合支架材料的原液注入3D生物打印机,3D打印成型得到胶原-胶原纤维复合支架,并将复合支架转移至在微波干燥机上成膜;随后接着将1.5重量份胶原溶液在0.1M的醋酸溶液中,配制成浓度为1.5wt%的胶原溶液胶原,使用静电喷涂机将上述胶原溶液喷涂在胶原-胶原纤维复合支架正反两面,最终经冷冻干燥、剂量为 15KGy/h60Co所产生的γ射线消毒灭菌,成型包装,得到基于胶原及胶原纤维的复合支架材料的最终成品。(3) Preparation of composite scaffold materials based on collagen and collagen fibers: According to the required scaffold shape and structure, computer-aided design software was used to compile a program to control the movement of the platform, and the stock solution of the composite scaffold materials based on collagen and collagen fibers was injected into the 3D Bioprinter, 3D printing to obtain a collagen-collagen fiber composite scaffold, and transfer the composite scaffold to a microwave dryer to form a film; then 1.5 parts by weight of collagen solution in 0.1M acetic acid solution to prepare a concentration of 1.5wt% Collagen solution collagen, using an electrostatic sprayer to spray the above collagen solution on the front and back sides of the collagen-collagen fiber composite support, finally freeze-dried, sterilized and sterilized by γ-rays produced by 15KGy/h 60 Co, molded and packaged, and obtained The final product of the composite scaffold material based on collagen and collagen fibers.
实施例3Example 3
(1)基于氧化多糖和氧化石墨烯的胶原-胶原纤维复合溶胀液的制备:将按质量比为9∶1的2重量份的胶原及胶原纤维混合, 10℃下搅拌将其溶胀于pH为4.0的醋酸-醋酸钠缓冲体系中,得到浓度为2wt%的胶原-胶原纤维复合溶胀液;接着向上述复合溶胀液中加入0.4重量份的氧化多糖, 10℃下避光反应10h,待反应完成后,再向复合溶胀液加入0.01重量份的氧化石墨烯,4~10℃下继续反应24h,得到基于氧化多糖和氧化石墨烯的胶原-胶原纤维复合溶胀液;(1) Preparation of collagen-collagen fiber composite swelling solution based on oxidized polysaccharide and graphene oxide: Mix 2 parts by weight of collagen and collagen fiber with a mass ratio of 9:1, stir at 10°C and swell it at a pH of In the acetic acid-sodium acetate buffer system of 4.0, a collagen-collagen fiber composite swelling solution with a concentration of 2wt% was obtained; then, 0.4 parts by weight of oxidized polysaccharide was added to the above composite swelling solution, and reacted in the dark at 10°C for 10 hours until the reaction was completed Finally, add 0.01 parts by weight of graphene oxide to the composite swelling solution, and continue to react for 24 hours at 4-10° C. to obtain a collagen-collagen fiber composite swelling solution based on oxidized polysaccharide and graphene oxide;
(2)基于胶原及胶原纤维的复合支架材料的原液的制备:将1.5重量份的壳聚糖加入到上述胶原-胶原纤维复合溶胀液, 10℃下搅拌至全部溶解,得到混合液A;在80℃下将6~12重量份的聚乙烯醇溶解在去离子水中,得到浓度为12wt%的聚乙烯醇水溶液;将按体积比为10∶0.01的混合A液与聚乙烯醇水溶液混合,10℃下搅拌至充分共溶,得到基于胶原及胶原纤维的复合支架材料的原液;(2) Preparation of stock solution of composite scaffold material based on collagen and collagen fibers: Add 1.5 parts by weight of chitosan to the above-mentioned collagen-collagen fiber composite swelling solution, stir at 10°C until completely dissolved, and obtain mixed solution A; Dissolve 6-12 parts by weight of polyvinyl alcohol in deionized water at 80°C to obtain a polyvinyl alcohol aqueous solution with a concentration of 12wt%; mix the mixed liquid A with a volume ratio of 10:0.01 with the polyvinyl alcohol aqueous solution, Stir at ℃ until fully co-dissolved to obtain a stock solution of a composite scaffold material based on collagen and collagen fibers;
(3)基于胶原及胶原纤维的复合支架材料的制备:根据所需支架形态、结构采用计算机辅助设计软件编制出控制平台移动的程序,将上述基于胶原及胶原纤维的复合支架材料的原液注入3D生物打印机,3D打印成型得到胶原-胶原纤维复合支架,并将复合支架转移至在微波干燥机上成膜;随后接着将2重量份胶原溶液在0.5M的醋酸溶液中,配制成浓度为2wt%的胶原溶液胶原,使用静电喷涂机将上述胶原溶液喷涂在胶原-胶原纤维复合支架正反两面,最终经冷冻干燥、剂量为 30KGy/h60Co所产生的γ射线消毒灭菌,成型包装,得到基于胶原及胶原纤维的复合支架材料的最终成品。(3) Preparation of composite scaffold materials based on collagen and collagen fibers: According to the required scaffold shape and structure, computer-aided design software was used to compile a program to control the movement of the platform, and the stock solution of the composite scaffold materials based on collagen and collagen fibers was injected into the 3D Bioprinter, 3D printing to obtain a collagen-collagen fiber composite scaffold, and transfer the composite scaffold to a microwave dryer to form a film; then 2 parts by weight of collagen solution in 0.5M acetic acid solution to prepare a concentration of 2wt% Collagen solution collagen, using an electrostatic sprayer to spray the above collagen solution on the front and back sides of the collagen-collagen fiber composite support, and finally freeze-dried, sterilized and sterilized by γ-rays produced by 30KGy/h 60 Co, molded and packaged, and obtained based on The final product of the composite scaffold material of collagen and collagen fibers.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710109808.7A CN106693050B (en) | 2017-02-28 | 2017-02-28 | A preparation method of composite scaffold material based on collagen and collagen fibers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710109808.7A CN106693050B (en) | 2017-02-28 | 2017-02-28 | A preparation method of composite scaffold material based on collagen and collagen fibers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106693050A CN106693050A (en) | 2017-05-24 |
| CN106693050B true CN106693050B (en) | 2019-09-13 |
Family
ID=58917874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710109808.7A Active CN106693050B (en) | 2017-02-28 | 2017-02-28 | A preparation method of composite scaffold material based on collagen and collagen fibers |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106693050B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108042854A (en) * | 2017-12-16 | 2018-05-18 | 诺迈尔(苏州)医学科技有限公司 | For the production technology of the gelatin fiber guide tissue regeneration film of Dental implant surgery |
| CN108340569B (en) * | 2018-01-04 | 2019-11-08 | 艾伯尔三氐打印技术(重庆)有限公司 | A 3D printing method for a three-dimensional cell-hydrogel composite structure |
| CN109464697A (en) * | 2018-12-26 | 2019-03-15 | 重庆石墨烯研究院有限公司 | A kind of polyvinyl alcohol/chitosan/graphene combine dressing and preparation method thereof |
| CN111378149B (en) * | 2018-12-30 | 2021-08-31 | 中国科学院沈阳自动化研究所 | A factor sustained-release neutral gel system for 3D printing or in situ injection and preparation method thereof |
| CN111501121A (en) * | 2019-01-31 | 2020-08-07 | 华北水利水电大学 | Method for preparing collagen fiber by wet spinning |
| CN112354013B (en) * | 2020-10-26 | 2022-10-18 | 杜明春 | Bionic collagen aqueous solution and preparation method and use method thereof |
| CN114149610A (en) * | 2021-12-17 | 2022-03-08 | 四川大学 | A method for preparing hemostatic sponge from oxidized Bletilla striata modified collagen fibers |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1319436A (en) * | 2001-02-28 | 2001-10-31 | 中国医学科学院生物医学工程研究所 | Compound collagen stroma tissue engineering support and preparation method thereof |
| WO2006096791A2 (en) * | 2005-03-07 | 2006-09-14 | Georgia Tech Research Corporation | Nanofilament scaffold for tissue regeneration |
| CN104013995A (en) * | 2014-06-26 | 2014-09-03 | 四川大学 | Oxidation chitosan graft modified porcine dermal collagen micro-nano fiber membrane and preparation method thereof |
| CN104761737A (en) * | 2015-04-15 | 2015-07-08 | 武汉理工大学 | Method for preparing collagen/graphene oxide nano fiber composite film by electrostatic spinning |
| CN105297168A (en) * | 2014-05-26 | 2016-02-03 | 中国科学院苏州纳米技术与纳米仿生研究所 | Oxidized graphene doped nano-fibers, as well as preparation method and application thereof |
-
2017
- 2017-02-28 CN CN201710109808.7A patent/CN106693050B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1319436A (en) * | 2001-02-28 | 2001-10-31 | 中国医学科学院生物医学工程研究所 | Compound collagen stroma tissue engineering support and preparation method thereof |
| WO2006096791A2 (en) * | 2005-03-07 | 2006-09-14 | Georgia Tech Research Corporation | Nanofilament scaffold for tissue regeneration |
| CN105297168A (en) * | 2014-05-26 | 2016-02-03 | 中国科学院苏州纳米技术与纳米仿生研究所 | Oxidized graphene doped nano-fibers, as well as preparation method and application thereof |
| CN104013995A (en) * | 2014-06-26 | 2014-09-03 | 四川大学 | Oxidation chitosan graft modified porcine dermal collagen micro-nano fiber membrane and preparation method thereof |
| CN104761737A (en) * | 2015-04-15 | 2015-07-08 | 武汉理工大学 | Method for preparing collagen/graphene oxide nano fiber composite film by electrostatic spinning |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106693050A (en) | 2017-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106693050B (en) | A preparation method of composite scaffold material based on collagen and collagen fibers | |
| Dutta et al. | Functional cellulose-based hydrogels as extracellular matrices for tissue engineering | |
| CN102886063B (en) | Preparation and application of cellulose nanocrystals (CNCs)-reinforced collagen compound substrate | |
| Jithendra et al. | Preparation and characterization of aloe vera blended collagen-chitosan composite scaffold for tissue engineering applications | |
| Ghorbani et al. | Hydrogels based on cellulose and its derivatives: applications, synthesis, and characteristics | |
| CN109821075B (en) | A kind of biological material, its preparation method and its application as a bone defect repair material | |
| CN105885436B (en) | Biological ink material for 3D printing and preparation method and application thereof | |
| Sun et al. | Fabrication of double-network hydrogels with universal adhesion and superior extensibility and cytocompatibility by one-pot method | |
| IL193640A (en) | Biodegradable foam | |
| CN102058902B (en) | Method for preparing mesh-shaped bionic bone porous stent material | |
| Liu et al. | Biomedical applications of bacterial cellulose based composite hydrogels | |
| Arisoly Xavier Acasigua et al. | Novel chemically modified bacterial cellulose nanocomposite as potential biomaterial for stem cell therapy applications | |
| CN102380128A (en) | Hydroxyapatite, sodium hyaluronate and konjac glucomannan composite material and preparation method thereof | |
| CN115054728A (en) | Bionic bone tissue engineering scaffold material and preparation method thereof | |
| CN113082295B (en) | A skin-derived acellular matrix-derived scaffold and its construction method | |
| CN110029499A (en) | Medical high polymer three-dimensional structure composite material and preparation method | |
| CN107213529A (en) | A kind of preparation method for being used to improve the degradable medical polymer three-dimensional material of Gegenbaur's cell adhesion and bone formation performance | |
| CN106860916A (en) | A kind of GO/nHA/ collagen composites bone renovating material and preparation method thereof | |
| CN106084302B (en) | Self-crosslinking hydroformylation nanometer bacteria cellulose functional porous material and preparation method | |
| CN105457107B (en) | A kind of bifunctional layer oral restoration film and preparation method thereof | |
| CN101264337B (en) | Preparation of collagen base biological medical material | |
| Gajurel et al. | Advances in synthetic strategies and applications of polymeric hydrogels | |
| Subramaniam et al. | In vitro biocompatibility assessment of a novel membrane containing magnesium-chitosan/carboxymethyl cellulose and alginate intended for bone tissue regeneration | |
| CN112043867A (en) | Heterogeneous double-layer porous collagen-based bone defect repair barrier membrane and preparation method thereof | |
| CN1285675C (en) | Composite collagen-base rack material and its pepn and use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |